Paydirt
XW
Insider

Xiaodong Wang

Director

Xiaodong Wang (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BGNE. The largest single filing was $13.4M of ONC (38,287 sh across 8 lots, as filed), executed Sep 8.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.4M
shares × price, as filed
Last traded
Sep 8
Filed Sep 10

Median ADV $130.5M across their filed names

Open performance
Volume by month
$13.4M$6.7M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $8.9MDec 2024 · sells $7.7MJan 2025 · sells $7.4MFeb 2025 · sells $9.4MMar 2025 · sells $12.9MApr 2025 · sells $10.0MMay 2025 · sells $9.3MJun 2025 · sells $11.4MSep 2026 · sells $13.4M
Buys $0 Sells $90.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
BGNE BGNE BGNE · 0 buys · 8 sells 8 filings ONC BeOne Medicines AG ONC · 0 buys · 3 sells 3 filings
Recent filings
BGNESALE BeiGene, Ltd. View filing → $7.4M
41,760 sh across 5 lots
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET
BGNESALE BeiGene, Ltd. View filing → $7.7M
41,460 sh across 10 lots
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET
BGNESALE BeiGene, Ltd. View filing → $8.9M
47,044 sh across 13 lots
Exec Nov 26 2024
Filed Nov 29 2024 · 5:30 PM ET